Cytarabine and Ammonia increased - a phase IV clinical study of FDA data

Summary:

Ammonia increased is reported as a side effect among people who take Cytarabine (cytarabine), especially for people who are female, 10-19 old, have been taking the drug for < 1 month also take Methotrexate, and have Acute lymphocytic leukemia (all).

The phase IV clinical study analyzes which people have Ammonia increased when taking Cytarabine. It is created by eHealthMe based on reports of 65,319 people who have side effects when taking Cytarabine from the FDA, and is updated regularly.

What is Cytarabine?

Cytarabine has active ingredients of cytarabine. It is often used in acute myelogenous leukemia (aml) - adult. eHealthMe is studying from 65,358 Cytarabine users. Check the latest studies of Cytarabine.

What is Ammonia increased?

Ammonia increased is found to be associated with 555 drugs and 764 conditions by eHealthMe. Check the latest studies of Ammonia increased.

On Jul, 21, 2026

65,319 people reported to have side effects when taking Cytarabine.
Among them, 44 people (0.07%) have Ammonia increased.

Could Cytarabine cause Ammonia increased?

Among these 44 people:

How long have people been on Cytarabine when they have Ammonia increased? *

What is the gender of people who have Ammonia increased when taking Cytarabine? *

female: 58.97 %
male: 41.03 %

What is the age of people who have Ammonia increased when taking Cytarabine? *

What are other drugs people take besides Cytarabine? *

What are other side effects people have besides Ammonia increased? *

Fever: 16 people, 36.36%
Arrhythmias (irregular heartbeat): 16 people, 36.36%
Thrombocytopenia (decrease of platelets in blood): 14 people, 31.82%
Blood Bilirubin Increased: 14 people, 31.82%
Alanine Aminotransferase Increased: 11 people, 25.00%
Aspartate Aminotransferase Increased: 11 people, 25.00%
Hyperbilirubinaemia (excess of bilirubin in the blood): 10 people, 22.73%
Confusional State: 10 people, 22.73%
Pneumonia: 10 people, 22.73%
High Blood Pressure: 10 people, 22.73%

What are the existing conditions these people have? *

Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 11 people, 25.00%
Leukaemia (blood or bone marrow cancer): 5 people, 11.36%
Hepatic Encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure): 1 person, 2.27%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 1 person, 2.27%
Allergic Rhinitis: 1 person, 2.27%
Aplasia Pure Red Cell (type of anaemia affecting the precursors to red blood cells but not to white blood cells): 1 person, 2.27%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 1 person, 2.27%
B Precursor Type Acute Leukaemia (lymphoid cancer): 1 person, 2.27%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 2.27%
Gout (uric acid crystals building up in the body): 1 person, 2.27%

* Approximation only. Some reports may have incomplete information.

Do you take Cytarabine and have Ammonia increased?

- Check whether Ammonia increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cytarabine:

Cytarabine (65,358 reports)

Browse all side effects of Cytarabine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ammonia increased:

Ammonia increased (555 drugs)

Browse all the conditions that are associated with Ammonia increased:

Ammonia increased (764 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cytarabine (the active ingredients of Cytarabine) and Cytarabine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.